Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study (Q61970364)
Jump to navigation
Jump to search
scientific article published in April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study |
scientific article published in April 2007 |
Statements
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study (English)
Ute Rupp
Eva Schoendorf-Holland
Michael Eichbaum
Florian Schuetz
Ilka Lauschner
Peter Schmidt
Alexander Staab
Gertraud Hanft
Jens Huober
Christof Sohn
Andreas Schneeweiss
1 April 2007